Loading...
NO-CANCER-NET logo

Project Title

Advanced Engineering of Nitric Oxide Based Therapeutics for Triple Negative Breast Cancer Training Network

Funds

EU-HORIZON-MSCA-2022-DN-101119873

Years

2023-2027

Main Research Area

GOALS

NO-CANCER-NET is a Horizon Europe Marie Skłodowska-Curie Actions (MSCA) Doctoral Network Training programme to address unmet medical need for Triple Negative Breast Cancer (TNBC). The network will train 10 doctoral candidates (DCs) across 6 European countries and 9 institutions, focusing on three areas centered on expanding nitric oxide (NO) based therapeutics for the treatment of TNBC. The main goal of NO-CANCER-NET is to equip DCs with experience and knowledge of the interdisciplinary expertise required to develop new therapeutics and diagnostics for areas of unmet clinical need.

Publications & Patents

Amir M. Alsharabasy, Godspower T. Isaac, Abhay Pandit; Engineering the Iron Center: Hemin Nanozymes for Programmable Cancer Catalysis. Nano Lett. 20 May 2026; 26 (19): 6205–6223. https://doi.org/10.1021/acs.nanolett.6c00429

Rizza S, Matrullo G, Martinez MB, et al. Post-transcriptional repression of GSNOR by microRNAs regulates S-nitrosylation and fuels breast cancer progression. Research Square; 2026. https://doi.org/10.21203/rs.3.rs-8532436/v1